Morrison & Foerster advised Crinetics Pharmaceuticals, Inc. on the offering, Wilson Sonsini Goodrich & Rosati advised Crinetics on patent matters and Cooley advised the underwriters. Crinetics...
Crinetics Pharmaceuticals’ $500 Million Common Stock Offering
Hume AI’s $12.7 Million Series A Investment
Morrison Foerster advised Hume AI Inc. on the deal. Hume AI Inc., a New York-based expressive communication research lab and startup, announced its $12.7 million Series...
Ingersoll Rand’s Acquisition of Dosatron International
Morrison Foerster advised Dosatron International on the deal. Dosatron International, a leading technology solutions provider of water powered dosing pumps and systems in North America, with...
Foxen Holdings’ $44 Million Series A Financing
Morrison Foerster advised Foxen Holdings on the deal. Foxen Holdings announced its $44 million Series A financing. Foxen is a developer of proprietary technology designed to provide...
9am.health’s $16 Million Series A Round
MoFo advised 9am.health on the deal. 9am.health completed its $16 million Series A financing round. 9am.health is a virtual diabetes clinic that offers personalized and affordable care...
Carlsmed’s $30 Million Series B Financing Round
MoFo advised Carlsmed on the deal. Carlsmed announced the completion of its $30 million Series B financing round. Carlsmed’s mission is to improve outcomes and decrease the...